RCP welcomes government commitment to ensuring new drugs are made available more quickly

Professor Margaret Johnson, RCP academic vice-president, today welcomed the Department of Health’s response to the Accelerated Access Review.  She said:

‘I welcome the government focus on putting patients and the NHS at the heart of innovation by ensuring new drugs are available more quickly.  I am also pleased to see efforts to ensure the UK remains a world leader post Brexit, and new measures to improve the drug approval system by reducing duplication and streamlining processes.  I also welcome the creation of the new advisory group to identify products called the Accelerated Access Collaborative – by including patients and clinicians as well as the industry we will achieve the sort of cross collaboration that is needed to steer future innovation priorities.’

Notes to Editors

Making a reality of the Accelerated Access Review: Improving patient access to breakthrough technologies and treatments in a cost-effective model is available here.